IL1B and Sepsis: This endotype ‘SRS1’, which was previously validated in other cohorts, was associated with an increased mortality and enrichment in response to IL-1 pathway in mature neutrophils, marking IL-1 out as a potential target for immunotherapy in these SRS1 sepsis patients [21].